These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Farge D Eur J Med; 1993; 2(6):339-43. PubMed ID: 8252179 [TBL] [Abstract][Full Text] [Related]
24. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. Stewart S; Jablonowski H; Goebel FD; Arasteh K; Spittle M; Rios A; Aboulafia D; Galleshaw J; Dezube BJ J Clin Oncol; 1998 Feb; 16(2):683-91. PubMed ID: 9469358 [TBL] [Abstract][Full Text] [Related]
25. DOXIL superior for KS. Posit Aware; 1995; ():7. PubMed ID: 11362576 [TBL] [Abstract][Full Text] [Related]
27. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Duman S; Töz H; Aşçi G; Alper S; Ozkahya M; Unal I; Celik A; Ok E; Başçi A Nephrol Dial Transplant; 2002 May; 17(5):892-6. PubMed ID: 11981080 [TBL] [Abstract][Full Text] [Related]
28. Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi's sarcoma in western Kenya. Strother RM; Gregory KM; Pastakia SD; Were P; Tenge C; Busakhala N; Jakait B; Schellhase EM; Rosmarin AG; Loehrer PJ Oncology; 2010; 78(1):5-11. PubMed ID: 20215784 [TBL] [Abstract][Full Text] [Related]
29. Post kidney transplantation Kaposi's sarcoma: the experience of a Mediterranean North African center. Gorsane I; Bacha MM; Abderrahim E; Amri N; Hajri M; Ounissi M; Harzallah A; El Younsi F; Hedri H; Ben Abdallah T Clin Transplant; 2016 Apr; 30(4):372-9. PubMed ID: 26782303 [TBL] [Abstract][Full Text] [Related]
30. Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Tessari G; Naldi L; Boschiero L; Cordiano C; Piaserico S; Fortina AB; Cerimele D; La Parola IL; Capuano M; Gotti E; Ruggenenti P; Sassi F; Remuzzi G; Girolomoni G Eur J Dermatol; 2006; 16(5):553-7. PubMed ID: 17101478 [TBL] [Abstract][Full Text] [Related]
31. Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma. Brambilla L; Miedico A; Ferrucci S; Romanelli A; Brambati M; Vinci M; Tedeschi L; Boneschi V J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1090-4. PubMed ID: 16987264 [TBL] [Abstract][Full Text] [Related]
32. Acute myeloid leukemia 4 years after Kaposi's sarcoma in a renal transplant recipient. Karakus S; Ozyilkan O; Akçali Z; Demirhan B; Haberal M Onkologie; 2004 Apr; 27(2):163-5. PubMed ID: 15138349 [TBL] [Abstract][Full Text] [Related]
33. Cytotoxic chemotherapy in Kaposi's sarcoma. Armentrout SA Adv Exp Med Biol; 1985; 187():159-62. PubMed ID: 2412417 [No Abstract] [Full Text] [Related]
34. Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers. Kreuter A; Rasokat H; Klouche M; Esser S; Bader A; Gambichler T; Altmeyer P; Brockmeyer NH Cancer Invest; 2005; 23(8):653-9. PubMed ID: 16377582 [TBL] [Abstract][Full Text] [Related]
35. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727 [TBL] [Abstract][Full Text] [Related]
36. Treatment of classical type Kaposi's sarcoma with paclitaxel. Chao SC; Lee JY; Tsao CJ Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806 [TBL] [Abstract][Full Text] [Related]
38. Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study. Delyon J; Rabate C; Euvrard S; Harwood CA; Proby C; Güleç AT; Seçkin D; Del Marmol V; Bouwes-Bavinck JN; Ferrándiz-Pulido C; Ocampo MA; Barete S; Legendre C; Francès C; Porcher R; Lebbe C; J Am Acad Dermatol; 2019 Aug; 81(2):448-455. PubMed ID: 30902727 [TBL] [Abstract][Full Text] [Related]
39. Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma. Plettenberg A; van Dyk U; Stoehr A; Albrecht H; Stellbrink HJ; Berger J; Meigel W Dermatology; 1997; 194(3):234-7. PubMed ID: 9187839 [TBL] [Abstract][Full Text] [Related]
40. Kaposi sarcoma in South African children. Stefan DC; Stones DK; Wainwright L; Newton R Pediatr Blood Cancer; 2011 Mar; 56(3):392-6. PubMed ID: 21225916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]